ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,996Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 676

$1.47M Total Retail Price of All Prescriptions

Rank: 17 out of 676

793 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 793 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

28% of this provider’s 793 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 19,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 961 587 S3 1 1
SIMVASTATIN 901 780 2 6
OMEPRAZOLE 853 674 3 2
FUROSEMIDE 777 629 4 4
POTASSIUM CHLORIDE 736 574 5 9
AMLODIPINE BESYLATE 709 547 6 3
LISINOPRIL 688 527 7 5
HYDROCHLOROTHIAZIDE 523 442 8 12
CARVEDILOL 520 414 9 15
LEVOTHYROXINE SODIUM 520 447 9 7
CITALOPRAM HBR 505 420 11 17
METFORMIN HCL 454 265 12 8
GLIMEPIRIDE 392 283 13 30
ZOLPIDEM TARTRATE 380 277 14 21
WARFARIN SODIUM 363 291 15 18
TRAMADOL HCL 359 257 16 19
GABAPENTIN 351 251 17 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 344 238 18 16
CRESTOR 305 190 19 29
CLONIDINE HCL 298 198 20 32
MELOXICAM 289 187 21 13
METOPROLOL TARTRATE 269 228 22 22
NEXIUM 268 151 23 23
ATORVASTATIN CALCIUM 268 198 23 20
ALENDRONATE SODIUM 259 212 25 61
ATENOLOL 258 168 26 25
METOPROLOL SUCCINATE 248 200 27 14
DIOVAN 246 199 28 37
DIOVAN HCT 239 192 29 41
PANTOPRAZOLE SODIUM 231 176 30 42
DONEPEZIL HCL 210 210 31 24
PRAVASTATIN SODIUM 198 155 32 11
LANTUS 188 152 33 55
CYCLOBENZAPRINE HCL 179 69 R 34 50
ACTOS 162 132 35 106
ZETIA 158 118 36 89
PROPRANOLOL HCL 154 115 37 120
ADVAIR DISKUS 151 114 38 87
POLYETHYLENE GLYCOL 3350 148 129 39 56
RANITIDINE HCL 144 117 40 27
NAPROXEN 143 95 41 71
NAMENDA 137 136 42 35
DIGOXIN 136 118 43 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 135 103 44 74
CYMBALTA 123 73 45 47
LYRICA 119 104 46 57
VERAPAMIL ER 115 91 47 101
MIRTAZAPINE 112 96 48 59
JANUVIA 110 94 49 78
ROPINIROLE HCL 110 101 49 85
LIPITOR 106 96 51 94
COLCRYS 106 82 51 122
SINGULAIR 103 64 53 80
VYTORIN 103 92 53 176
FLUTICASONE PROPIONATE 101 42 55 49
KLOR-CON M20 97 74 56 67
JANTOVEN 95 85 57 156
NIFEDIPINE ER 93 53 58 100
CEFUROXIME 92 66 59 121
CLOPIDOGREL 91 62 60 28
ESCITALOPRAM OXALATE 91 73 60 73
AZITHROMYCIN 91 69 60 39
INSULIN SYRINGE 90 71 63 161
ISOSORBIDE MONONITRATE ER 87 84 64 54
TRILIPIX 87 54 64 232
AMLODIPINE BESYLATE-BENAZEPRIL 87 55 64 44
TRAZODONE HCL 86 82 67 36
ALLOPURINOL 84 53 68 31
TAMSULOSIN HCL 83 62 69 38
LEVOFLOXACIN 82 69 70 91
SPIRONOLACTONE 81 56 71 62
AMOX TR-POTASSIUM CLAVULANATE 79 48 72 136
DILTIAZEM 24HR CD 78 64 73 152
NITROFURANTOIN MONO-MACRO 76 62 74 182
PLAVIX 75 50 75 40
CIPROFLOXACIN HCL 75 56 75 45
BENAZEPRIL HCL 75 49 75 58
RISPERIDONE 74 70 78 69
EVISTA 74 65 78 119
NOVOLOG MIX 70-30 72 72 80 203
MECLIZINE HCL 72 48 80 83
AMITRIPTYLINE HCL 69 46 R 82 46
TRIAMTERENE-HCTZ 67 26 83 43
QUINAPRIL HCL 65 65 84 151
ESTRADIOL 65 33 R 84 109
SYNTHROID 65 65 84 48
DILTIAZEM 24HR ER 64 51 87 215
NIFEDIAC CC 64 47 87 382
ONGLYZA 64 46 87 178
ARICEPT 63 49 90 383
GLIPIZIDE 63 45 90 81
PROMETHAZINE HCL 63 14 R 90 75
PIOGLITAZONE HCL 63 53 R 90 266
CARISOPRODOL 62 12 R 94 60
PAROXETINE HCL 60 27 95 65
ENDOCET 58 22 S2 96 104
NOVOLIN 70-30 57 46 97 181
IBUPROFEN 56 22 98 102
KETOCONAZOLE 56 36 98 406
PRAMIPEXOLE DIHYDROCHLORIDE 55 54 100 204
FAMOTIDINE 55 48 100 64
BENZTROPINE MESYLATE 55 44 R 100 129
PROAIR HFA 54 25 103 79
MEGACE ES 54 49 R 103 411
AMIODARONE HCL 54 43 103 154
NOVOLOG 54 46 103 134
QUETIAPINE FUMARATE 54 39 103 72
ENALAPRIL MALEATE 54 54 103 65
FLUCONAZOLE 53 26 109 115
PHENYTOIN SODIUM EXTENDED 52 18 110 88
BYETTA 51 27 111 331
SERTRALINE HCL 50 37 112 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.